AdaptHealth (AHCO) Expected to Announce Earnings on Tuesday

Key Points

• AdaptHealth is set to report Q1 2026 results before the market opens on Tuesday, May 5, 2026, with analysts forecasting $0.0113 EPS and $796.63 million in revenue; a conference call is scheduled for 8:30 AM ET.
• The company recently posted a steep EPS miss for the prior quarter (reported -$0.76 vs. a consensus of $0.34) despite a revenue beat, and analysts on average rate the stock a Hold with a $13.00 target while projecting about $1 EPS for the current and next fiscal year.
• Insider activity is notable: major shareholder Richard M. Cashin Jr. bought 820,528 shares at ~$9.73 in March (a ~5.94% increase in his position), and institutional investors now own roughly 82.67% of the company.

AdaptHealth (NASDAQ:AHCO - Get Free Report) is expected to release its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect AdaptHealth to post earnings of $0.0113 per share and revenue of $796.6310 million for the quarter. Interested persons can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 8:30 AM ET.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last issued its quarterly earnings data on Tuesday, February 24th. The company reported ($0.76) EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($1.10). The company had revenue of $846.29 million for the quarter, compared to the consensus estimate of $832.51 million. AdaptHealth had a positive return on equity of 3.42% and a negative net margin of 2.18%.AdaptHealth's quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.34 earnings per share. On average, analysts expect AdaptHealth to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

AdaptHealth Price Performance

Shares of AHCO opened at $13.08 on Tuesday. The company has a market cap of $1.78 billion, a P/E ratio of -23.78, a PEG ratio of 1.47 and a beta of 1.50. The stock has a fifty day moving average price of $11.02 and a 200 day moving average price of $10.27. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.02 and a quick ratio of 0.81. AdaptHealth has a 12 month low of $7.91 and a 12 month high of $13.30.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AHCO. Jefferies Financial Group restated a "hold" rating and set a $11.00 price objective on shares of AdaptHealth in a research note on Monday, April 20th. Royal Bank Of Canada restated an "outperform" rating and set a $13.00 price objective on shares of AdaptHealth in a research note on Wednesday, February 25th. Wall Street Zen downgraded AdaptHealth from a "buy" rating to a "hold" rating in a research note on Saturday, February 28th. Weiss Ratings downgraded AdaptHealth from a "hold (c-)" rating to a "sell (d)" rating in a research note on Wednesday, February 25th. Finally, Leerink Partners lowered their price objective on AdaptHealth from $13.00 to $12.00 and set an "outperform" rating for the company in a research note on Thursday, February 26th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, AdaptHealth presently has an average rating of "Hold" and an average target price of $13.00.

Insider Activity

In other AdaptHealth news, major shareholder Richard M. Cashin, Jr. purchased 820,528 shares of the firm's stock in a transaction dated Tuesday, March 10th. The stock was bought at an average price of $9.73 per share, with a total value of $7,983,737.44. Following the completion of the purchase, the insider owned 14,638,708 shares in the company, valued at $142,434,628.84. This trade represents a 5.94% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders acquired a total of 2,494,518 shares of company stock valued at $24,352,291 over the last ninety days. Corporate insiders own 1.55% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Brooklyn Investment Group bought a new position in shares of AdaptHealth in the fourth quarter worth $328,000. Graham Capital Management L.P. lifted its holdings in shares of AdaptHealth by 38.4% in the fourth quarter. Graham Capital Management L.P. now owns 29,992 shares of the company's stock valued at $299,000 after buying an additional 8,316 shares during the period. BNP Paribas Financial Markets lifted its holdings in shares of AdaptHealth by 53.9% in the second quarter. BNP Paribas Financial Markets now owns 28,159 shares of the company's stock valued at $266,000 after buying an additional 9,861 shares during the period. Corient Private Wealth LLC lifted its holdings in shares of AdaptHealth by 8.6% in the fourth quarter. Corient Private Wealth LLC now owns 22,562 shares of the company's stock valued at $227,000 after buying an additional 1,794 shares during the period. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in shares of AdaptHealth in the second quarter valued at $189,000. Institutional investors own 82.67% of the company's stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company's respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.